Composition
US-2015351393-A1 · Dec 10, 2015 · US
Method of treatment
US10875830B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10875830-B2 |
| Application number | US-201716317269-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 13, 2017 |
| Priority date | Jul 21, 2016 |
| Publication date | Dec 29, 2020 |
| Grant date | Dec 29, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Lactams for use in the treatment of respiratory tract infections, including chronic lung infections in patients having cystic fibrosis.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treatment of cystic fibrosis in a subject comprising: administering to the subject an effective amount of a lactam of 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one.
Assignees
Inventors
Classifications
Drugs for disorders of the respiratory system · CPC title
having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide · CPC title
Antibacterial agents · CPC title
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title
- A61K31/402Primary
1-aryl substituted, e.g. piretanide · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10875830B2 cover?
- Lactams for use in the treatment of respiratory tract infections, including chronic lung infections in patients having cystic fibrosis.
- Who is the assignee on this patent?
- Conopco Inc, Conopeo Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/402. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).